IP Library Granted Patent US 12662626
Granted Patent B2
US 12662626 · App. 17/756,810 · Granted Jun 23, 2026

Dicationic fluorescent dyes

Inventor: Alexander Nierth (Dublin, CA)
Assignee: Roche Molecular Systems, Inc.
C09K11/06C09B11/28C12Q1/6851G01N33/533C09K2211/1018C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12662626
App. No.
17/756,810
Filed
Jun 2, 2022
Granted
Jun 23, 2026
Kind
B2
Examiner
RILEY, JEZIA
Art Unit
1681
USPC
435/6.12
Abstract

The present invention provides for water-soluble mono- and dicationic fluorescent dyes with the latter exhibiting stable fluorescence at elevated temperatures. The present invention also provides for methods for the production of the fluorescent dyes and for using these dyes in biological assays such as multiplexing qPCR and tissue staining.

Claims (28)

1 . A fluorescent dye of Formula A or B

wherein:

X=Si, Ge, or C;

Y=Me, Et, iPr, or Ph;

Z=any one of:

W=any one of:

R 1 and R 2 are any combination of:

and L=H, SO 3 H, CONH 2 , CO 2 H, N 3 , or a moiety subject to click chemistry functionality selected from the group consisting of an alkyne and an azide.

2 . The fluorescent dye of claim 1 , wherein Z=any one of:

3 . The fluorescent dye of claim 2 , wherein Z=

4 . The fluorescent dye of claim 1 , wherein the dye is selected from the group consisting of

5 . A method for preparing the fluorescent dyes of claim 1 , the method comprising the steps of:

a) performing a double halogen-metal exchange of a dihalogenide to the corresponding dilithium compound with an organolithium reagent;

b) reacting the dilithium compound with an alkylester to form a hydroxyl-intermediate;

c) adding a Brønsted acid to the hydroxyl-intermediate for performing an aromatization by elimination of water to form an imidazole; and

d) quarternization of the imidazole to imidazolium.

6 . The method of claim 5 , wherein quarternization is performed by nucleophilic substitution with an alkylhalogenide, alkyltosylate, alkyltriflate, or alkylmesylate.

7 . The method of claim 5 , wherein quarternization is performed with a cyclic lactone in the presence of a Lewis acid.

8 . The method of claim 5 , wherein quarternization is performed with in situ generated aryne from a 2-(trimethylsilyl) phenyl trifluoromethanesulfonate reagent and a fluoride donor.

9 . A method of detecting the presence of one or more target nucleic acids in a sample in a polymerase chain reaction (PCR) assay by

contacting said sample with an oligonucleotide probe labeled with at least one fluorescent dye of claim 1 ; and

measuring a fluorescent signal generated from the labeled oligonucleotide whereby the detection of the fluorescent signal indicates the presence of the one or more target nucleic acids in the sample.

10 . The method of claim 9 , wherein the PCR assay is a multiplex PCR assay.

11 . The method of claim 9 , wherein measuring the fluorescent signal takes place at a temperature at or above 65° C.

12 . A method of detecting the presence of one or more target proteins in a tissue sample in an immunohistochemical assay by

contacting said tissue sample with a binding entity labeled with at least one fluorescent dye of claim 1 that directly or indirectly interacts with said target proteins; and

visualizing a fluorescent signal generated in the tissue sample whereby the detection of the fluorescent signal indicates the presence of the one or more target protein in the tissue sample.

13 . The method of claim 12 , wherein the binding entity is a primary antibody that binds to the one or more target proteins or a secondary antibody that binds to the primary antibody.